Actinium Pharmaceuticals Inc

Penny Stocks Biotech Stocks Healthcare Stocks

$1.59

+0.00 (+0.00%)

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 8 89%

Hold 1 11%

Sell 0 0%

Price Target

Analyst Price Target +2,171.1% upside

Low Target $23.47

Average Target $36.11

High Target $39.96

Current Price $1.59

Current
$1.59

Target
$36.11

$23.47 $36.11 avg $39.96

Scenario Analysis

Bear Case

$23.47

1,376.1%

Low target

Base Case

$36.11

+2,171.1%

Avg target

Bull Case

$39.96

+2,413.2%

High target

Risk/Reward

1.8x

Balanced

Price in Context

52-Week High

$1.72

-7.6% from high

52-Week Low

$0.74

+116.3% from low

Target vs 52W High

$36.11

+1,999.4% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	38	82%	$257.58	-12.5%
AMGN Amgen Inc	Hold	42	43%	$190.87	-59.0%
GILD Gilead Sciences Inc	Strong Buy	36	83%	$362.68	+115.4%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	39	82%	$438.34	-18.5%
MRNA Moderna Inc	Hold	31	32%	$149.45	-35.4%
REGN Regeneron Pharmaceuticals	Buy	36	72%	$76.80	-91.9%
NTRA Natera Inc	Strong Buy	31	90%	$142.91	-55.7%
RVMD Revolution Medicines Inc	Strong Buy	31	94%	$114.11	-35.3%